Results 1 to 10 of about 6,563 (227)

Bisphosphonate Associated Osteonecrosis of the Jaw: An Update on Pathophysiology, Risk Factors, and Treatment [PDF]

International Journal of Dentistry, 2014
Osteonecrosis of the jaw in patients treated with bisphosphonates is a relatively rare but well known complication at maxillofacial units around the world. It has been speculated that the medication, especially long-term i.v.
Lars Rasmusson, Jahan Abtahi
doaj   +3 more sources

Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis [PDF]

Case Reports in Oncological Medicine, 2014
Osteonecrosis of the jaw is usually a potential complication of bisphosphonate therapy. In a cancer patient, this disease entity can be misdiagnosed as a metastatic lesion. Our aim is to make clinicians aware of bisphosphonate associated osteonecrosis of
Geetika Bhatt, Aashish Bhatt, Anthony E. Dragun, Xiao-Feng Li, A. Cahid Civelek   +4 more
doaj   +2 more sources

CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma

Haematologica, 2011
Osteonecrosis of the jaw is an uncommon but potentially serious complication of bisphosphonate therapy in multiple myeloma. Previous studies showed that the presence of one or two minor alleles of the cytochrome P450, subfamily 2C polypeptide 8 gene ...
Esperanza Such, José Cervera, Evangelos Terpos, José V Bagán, Amparo Avaria, Inés Gómez, María Margaix, Mariam Ibañez, Irene Luna, Lourdes Cordón, Mónica Roig, Miguel A. Sanz, Meletios A. Dimopoulos, Javier de la Rubia   +13 more
doaj   +2 more sources

Bisphosphonate-associated osteonecrosis can hide jaw metastases [PDF]

Bone, 2007
Background: Osteonecrosis of the jaw is a well known potential complication of bisphosphonate treatment but its pathogenesis is poorly understood. The current management of patients with bisphosphonate-associated osteonecrosis (BON) is based on “expert ...
M. Ragazzo, E. D'Alessandro, Capelli, Paola, G. Bettini, L. Lo Muzio, S. Blandamura, L. Lo Russo, G. Saia, BEDOGNI, Alberto, NOCINI, Pier Francesco   +9 more
core   +5 more sources

Bisphosphonate Related Osteonecrosis of the Jaw: A Study of 18 Cases Associated with Fungal Infection [PDF]

International Journal of Dentistry, 2014
Osteonecrosis of the jaw (ONJ) is a serious complication associated with oral and intravenous bisphosphonate therapy. Its pathogenesis is not well understood and its management is difficult.
V. Aftimos, T. Zeinoun, R. Bou Tayeh, G. Aftimos   +3 more
doaj   +2 more sources

Clinical Experience with Spiramycin in Bisphosphonate-Associated Osteonecrosis of the Jaw

International Journal of Immunopathology and Pharmacology, 2010
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) consists of an exposure of the jaw bone that persists for over 8 weeks in patients with positive history for bisphosphonates. Symptomatology is characterized by dull and ceaseless pain, and in advanced stages, the exposure of necrotic bone is evident, which is frequently associated with purulent ...
Giulio Gasparini, Alessandro Moro, S Pelo   +2 more
exaly   +3 more sources

Bisphosphonate-associated osteonecrosis of the jaw

Indian Journal of Rheumatology, 2008
I Pande
doaj   +4 more sources

Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report

Clinical Interventions in Aging, 2014
Licia Manzon,1 Evaristo Ettorre,1 Giovanni Viscogliosi,1 Stefano Ippoliti,1 Fabio Filiaci,2 Claudio Ungari,2 Giovanni Fratto,1 Alessandro Agrillo2 1Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences ...
Manzon L, Ettorre E, Viscogliosi G, Ippoliti S, Filiaci F, Ungari C, Fratto G, Agrillo A   +7 more
doaj   +1 more source

Bisphosphonate Associated Osteonecrosis of the Jaw [PDF]

The Journal of Rheumatology, 2009
In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving bisphosphonates (BP) were published. These cases occurred in patients with cancer receiving high-dose intravenous BP; however, 5% of the cases were in patients with osteoporosis receiving low-dose bisphosphonate therapy.
Aliya A, Khan, George K B, Sándor, Edward, Dore, Archibald D, Morrison, Mazen, Alsahli, Faizan, Amin, Edmund, Peters, David A, Hanley, Sultan R, Chaudry, Brian, Lentle, David W, Dempster, Francis H, Glorieux, Alan J, Neville, Reena M, Talwar, Cameron M, Clokie, Majd Al, Mardini, Terri, Paul, Sundeep, Khosla, Robert G, Josse, Susan, Sutherland, David K, Lam, Robert P, Carmichael, Nick, Blanas, David, Kendler, Steven, Petak, Louis Georges, Ste-Marie, Jacques, Brown, A Wayne, Evans, Lorena, Rios, Juliet E, Compston   +29 more
openaire   +4 more sources

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation [PDF]

Journal of Dentistry, 2023
Statement of the Problem: One of the rare adverse effects in patients who take bisphosphonates is the osteonecrosis of the jaw in the oral cavity following any trauma such as tooth extraction.Purpose: The aim of this study is the histopathological ...
Saeed Moradi, Bibi Marjan Razavi, Siavash Moushekhian, Narges Poormahmood, Mohammad Marvi   +4 more
doaj   +1 more source